U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07068126) titled 'Management of Children With Persistent ITP, A Novel Approach' on July 02.
Brief Summary: The goal of this clinical trial is to learn if mini-pool intravenous immunoglobulin (IVIG) is a safe and effective treatment for children with persistent immune thrombocytopenia (ITP). ITP is a condition that causes low platelet levels and increases the risk of bleeding. The main questions this study aims to answer are:
Can mini-pool IVIG raise platelet levels in children with persistent ITP?
Can it reduce bleeding episodes and hospital visits?
What side effects, if any, are seen with this treatment?
There is no comparison group in this stud...